Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

0.8551 -0.0149 (-1.71%)
Streaming Delayed Price Updated: 2:31 PM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bionano Genomics Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Vinco Ventures (BBIG) Stock Pops on CEO Announcement, Legal Settlement
Vinco Ventures (BBIG) stock is jumping on Wednesday after the company announced a new CEO and the end of a legal battle. 
Via InvestorPlace
Why Is Bionano Genomics (BNGO) Stock Up 11% Today?
Bionano Genomics (BNGO) stock is rising higher on Wednesday following the publication of a study related to optical genome mapping (OGM). 
Via InvestorPlace
Why Bionano Genomics Stock Continues To Surge
Bionano Genomics Inc (NASDAQ: BNGO) shares continue to trade higher Wednesday after the company on Tuesday highlighted a study showing that optical genome mapping better detected structural variations... 
Via Benzinga
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another overview of the biggest pre-market stock movers for Wednesday as we cover the news behind share movement this morning! 
Via InvestorPlace
Recap: Bionano Genomics Q2 Earnings
Bionano Genomics (NASDAQ:BNGO) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Bionano Genomic (BNGO) Stock Pops on Research Study
Bionano Genomic is in the news today as a landmark research focusing on genomic mapping technology bolsters BNGO stock. 
Via InvestorPlace
Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket
Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada. 
Via Benzinga
If You Invested $1,000 In BioNano (BNGO) Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than... 
Via Benzinga
7 Penny Stocks to Buy Now for Extraordinary Gains
While most investors should probably stay away from penny stocks, for hardened gamblers, these ideas may carry upside potential. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
Hold On to Bionano Genomics Stock Until It Reaches $6 at Least
After a year of blockbuster revenue growth, BNGO stock deserves a major re-rating 
Via InvestorPlace
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
7 Hot Growth Stocks Poised to Triple by 2030
For multiple reasons, this looks like a wonderful time for investors to buy hot growth stocks with very strong outlooks. 
Via InvestorPlace
7 Cheap Penny Stocks to Buy Before They Boom
If you have the stomach for extreme speculation, these cheap penny stocks to buy could move higher (but be ready for anything). 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
What In The World Is Going On With Bionano Genomics Shares?
Bionano Genomics, Inc. (NASDAQ: BNGO) are trading higher by 11.8% to $3.36 Thursday afternoon. The company Thursday morning today announced the publication of the first study to evaluate the utility of... 
Via Benzinga
Why Is Bionano Genomics (BNGO) Stock Up 20% Today?
Bionano Genomics is in the news again, delivering groundbreaking nanoscale analytics research that has BNGO stock reaching for the stars. 
Via InvestorPlace
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Thursday, 7/28, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
The 7 Best Stocks to Buy on a Dip in July
With the stock market pricing in a recession that likely won't arrive anytime soon, these are some of the best stocks to buy on a dip. 
Via InvestorPlace
3 Stocks That Could Double in 2022
With the market shaking off its downturn and the economy strengthening, there are several stocks that could double before the year is out. 
Via InvestorPlace
Looking Into Bionano Genomics's Return On Capital Employed
Bionano Genomics (NASDAQ:BNGO) brought in sales totaling $5.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 30.52%, resulting in a loss of $29.95 million. 
Via Benzinga
7 Cheap Biotech Stocks to Buy Now
These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains. 
Via InvestorPlace
Bionano Genomics's Earnings Outlook
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Bionano... 
Via Benzinga
The Latest Studies by Bionano Genomics Are Promising, But It’s Not a Buy Yet
BNGO stock has provided positive news from study results lately, but its fundamentals are not great and not a reason to invest in it now. 
Via InvestorPlace
Why Bionano Genomics Stock Is Risky, but a Good Bet
The risks may be clear when it comes to Bionano Genomics and BNGO stock. However, investors should see this as a long-term play. 
Via InvestorPlace
Bionano Genomics Stock Can Regain the Crucial $5 Level
Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon. 
Via InvestorPlace
Bionano Genomics May Finally Offer a Reward for Your Risk
BNGO stock has been a falling knife for the past year. But, with promising fundamentals and good tailwinds, now be the time to take a chance. 
Via InvestorPlace
Bionano Genomics's Return On Capital Employed Insights
Benzinga Pro data, Bionano Genomics (NASDAQ:BNGO) reported Q4 sales of $6.30 million. Earnings fell to a loss of $22.95 million, resulting in a 10.58% decrease from last quarter... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.